Huge congratulations to CREATE Fellow Dr Gang Liu who has been awarded a 2025 Al and Val Rosenstrauss Fellowship by the Rebecca L. Cooper Medical Research Foundation.
These fellowships provide $1 million in funding for 5 years, to support rising stars in Australian medical research who are leading cutting-edge research on major diseases.
Dr Liu was awarded the fellowship for his project: using AI and big data to understand lung fibrosis.
In this project, Dr Liu, a senior lecturer in the UTS School of Life Sciences, is using artificial intelligence and molecular research techniques to understand how people develop lung fibrosis and explore potential therapies.
People with idiopathic pulmonary fibrosis (IPF) typically only survive two to five years after being diagnosed. The disease has no known cause or cure, with only 2 drugs available to treat it Dr Liu told UTS.
“My research aims to develop new and more effective therapies for this debilitating condition. This program will improve diagnosis by creating new AI software, explore how fibrosis progresses at the cellular level using large-scale biology data, and optimise treatments to halt and hopefully reverse this progress using gene therapies,” he said.